Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x100px
Organisation › Details

MindImmune Therapeutics Inc.

MindImmune is a biotech company targeting the immune system to treat brain disease. The company was founded in 2016 in the US and is based at the University of Rhode Island. It is affiliated with the George & Anne Ryan Institute for Neuroscience, a multidisciplinary research center focused on discovering and developing disease-modifying therapies for neurodegenerative disorders. *

 

Period Start 2016-01-01 established
Products Industry CNS drug (neurological drug)
  Industry 2 drug development
     
Region Region Kingston, RI
  Country United States (USA)
  City n. a. Kingston, RI
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for »About Section«: H. Lundbeck A/S. (5/22/18). "Press Release: Lundbeck Divests Preclinical Research Programs. Two Programs Outside Lundbeck's Areas of Focus Are Transferred to MindImmune Therapeutics, Inc.". Valby.
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for MindImmune Therapeutics Inc.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top